Annals of Clinical and Medical Case Reports Review Article ISSN 2639-8109 Volume 6 Allergic Reactions to Covid19 (Sars-Cov-2) Vaccine Quel J* Department of Allergy and Asthma, Hispanic-American Allergy, Asthma and Immunology Association (HAAMA), USA *Corresponding author: Received: 12 Feb 2021 Copyright: Accepted: 01 Mar 2021 ©2021 Quel J et al., This is an open access article distrib- Jorge Quel, Published: 05 Mar 2021 uted under the terms of the Creative Commons Attribu- Department of Allergy and Asthma, tion License, which permits unrestricted use, distribution, Hispanic-American Allergy, and build upon your work non-commercially. Asthma and Immunology Association (HAAMA), USA, E-mail:
[email protected] Citation: Quel J. Allergic Reactions to Covid19 (Sars-Cov-2) Vaccine. Ann Clin Med Case Rep. 2021; V6(1): 1-4 1. Background CDC considers a history of the following to be a contradiction The recent approval of various covid vaccines will result in mas- to vaccination with both the Pfizer BioNTech and Moderna sive immunization of the public with these vaccines. Cases of al- COVID-19 vaccine: lergic reactions such as rashes, urticaria, anaphylaxis have been re- Severe allergic reaction (eg anaphylaxis) after a previous does of ported worldwide. The following is a summary, from an allergist’s an mRNA COVID-19 vaccine or any of its components. perspective, of the components found to be present in situations Immediate allergic reaction of any severity to a previous dose of where the patient has experienced an allergic reaction to the Covid an mRNA COVID-19 vaccine or any of its components (including 19 vaccine.